Good morning, everyone, and apologies for the late start. We experienced a computer glitch that delayed our ability to proceed with our usual routine. Nothing like aggravation first thing in the morning, yes? Well, stuff happens. Now, here we are with a cup of stimulation in hand and a few tidbits to help you get started. Hope your day goes well - and ours improves - and good things happen for all. Stay in touch...
Novartis Earnings Hit By Manufacturing Problems (Wall Street Journal)
A 'Polypill' For The Over-50 Crowd? (Reuters)
Pharma Is Not Making The Most Of Its Data (Pharma Times)
UN Says Funding Boost Helped Decline In HIV (Pharma Times)
Is Breaking Up J&J The Right Thing To Do? (USA Today)
Indian Drugmakers Agree To Enforcing Marketing Code (Zee News)
Drugmakers Are Silent On Impact Of Opioids REMS (InPharma Technologist)
Bill Aims To Deter Painkiller Abuse (Wall Street Journal)
Galena Wins Patent For Cancer Vaccine (Associated Press)
Sanofi And Brigham To Collaborate On Diabetes (Boston Globe)
EDITOR'S NOTE: Please check this post for updates during the day
1 Comment